Director dealings

Few people are better placed to evaluate a company's prospects than those who actually run it, which is why many investors regard directors' share dealings as a key indicator of future prospects.

Transactions

Dealing date
Company
& ticker
Name & title
Number
of shares
Deal size
Purchase
17 May 2013
GlaxoSmithKline PLC
GSK:LSE
Sir Andrew Witty
Chief Executive Officer
2153.66kGBP
Purchase
17 May 2013
Marston's PLC
MARS:LSE
P Dalzell
--
10,00014.72kGBP
Purchase
17 May 2013
Ocado Group PLC
OCDO:LSE
Sir Stuart Rose
Chairman
452,2849.05kGBP
Purchase
17 May 2013
Universal Health Services Inc
UHS:NYQ
John H. Herrell
--
3,750113.70kUSD
Purchase
17 May 2013
Universal Health Services Inc
UHS:NYQ
John H. Herrell
--
3,750138.56kUSD
Purchase
17 May 2013
Universal Health Services Inc
UHS:NYQ
John H. Herrell
--
7,500327.53kUSD
Purchase
17 May 2013
Universal Health Services Inc
UHID:QBB
John H. Herrell
--
3,750113.70kUSD
Purchase
17 May 2013
Universal Health Services Inc
UHID:QBB
John H. Herrell
--
3,750138.56kUSD
Purchase
17 May 2013
Universal Health Services Inc
UHID:QBB
John H. Herrell
--
7,500327.53kUSD
Purchase
17 May 2013
Wolfson Microelectronics PLC
WLF:LSE
R K Graham
--
22,44650.00kGBP
1-10 of 1,107 results

Latest director dealing news

Yesterday's stars are today's crooksSAC changes stance on insider trade probe
UK directors' deals: Ideagen, Treatt, Quindell, HikmaLevel Global's Anthony Chiasson given more than six years in jail

Latest corporate regulatory announcements

Time & dateCompanyHeadlineSource
20 May 2013
5:48 PM
ITE Group PLC
ITE:LSE
Director/PDMR ShareholdingRNS
20 May 2013
5:46 PM
ITE Group PLC
ITE:LSE
Director/PDMR ShareholdingRNS
20 May 2013
5:37 PM
Oakley Capital Investments Limited
OCL:LSE
Director/PDMR ShareholdingRNS
20 May 2013
5:21 PM
Jardine Lloyd Thompson Group PLC
JLT:LSE
Director/PDMR ShareholdingRNS
20 May 2013
4:51 PM
Kier Group PLC
KIE:LSE
Director/PDMR ShareholdingRNS
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.